Clinical trials
Phase 4 Anemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 7 |
| 2005 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 9 |
| Withdrawn | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Watson Pharmaceuticals | 5 |
| Amgen | 2 |
| University of Maryland, Baltimore | 2 |
| Weill Medical College of Cornell University | 2 |
| American Regent, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Children's Hospital Los Angeles | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Emory University | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 32 |
| Renal Insufficiency, Chronic | 9 |
| Anemia, Iron-Deficiency | 7 |
| Iron Deficiencies | 6 |
| Kidney Failure, Chronic | 4 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Renal Insufficiency | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anemia, Sickle Cell | 1 |
| Arthritis | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.